Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
Sanobiotec
Sanobiotec
Activities:
Ingredients
Dietary supplements
Active Nutrition
Food
X
LinkedIn
Trending Articles
From subscriptions to mushrooms: BCMPA members discuss the latest outsourcing trends in nutraceuticals
From single-serve sachets catering to the busy on-the-go market to specialised subscription models shaping direct-to-consumer interactions, the nutraceutical industry is...
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
LifeinU BSCU1: embrace your health now and for the future
New biotics solutions are flooding the market to capitalise on the ever-changing immunity seeking consumer. However, one probiotic solution, LifeinU® BSCU1 from Gnosis by...
Macalat earns NEXTY award for chocolate mushroom mycelium technology
The organic brand has created a novel category in the chocolate industry: sweet dark chocolate
Mibelle Biochemistry has strengthened its beauty-from-within portfolio
PhytoCellTec Md Nu, a novel anti-aging solution, utilises the power of apple fruit cell culture extract to boost skin stem cell vitality and enhance skin density, elasticity,...
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Ingredients
Sanobiotec refines CBC cannabinoid production
CBC has been explored for use as an antibacterial, acne medication, and migraine therapy
Finance
Sanobiotec inks agreement with OBX
Sanobiotec believes expanding the supply of high-purity products will act as a stimulus for market players to explore compound applicability with greater consistency
Research & Development
Sanobiotec trialling CBDV for ASD benefits
These results follow the FDA’s decision to grant CBDV ‘orphan designation’ in the treatment of Fragile X and Rett syndromes
Ingredients
Sanobiotec synthesizes THCV cannaboid for chronic disease treatment
Sanobiotec has synthesised pure and stable THCV, joining a minor group of players in the cannabis production market who have successfully done so
Ingredients
Sanobiotec taps into potential of minor cannabinoids
Minor cannabinoids have a wide variety of health-beneficial properties; however, there’s little research on the topic owing to their scarcity in the hemp biomass and difficult extraction processes
Subscribe now